Heron Therapeutics, Inc. (HRTX)
0.3178
0.00 (0.00%)
USD |
NASDAQ |
Sep 02, 16:00
0.3178
0.00 (0.00%)
After-Hours: 16:54
Heron Therapeutics Cash from Investing (Quarterly) : -3.265M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.265M |
| March 31, 2026 | -0.939M |
| December 31, 2025 | -5.456M |
| September 30, 2025 | 11.86M |
| June 30, 2025 | 7.334M |
| March 31, 2025 | 2.273M |
| December 31, 2024 | 11.42M |
| September 30, 2024 | 3.97M |
| June 30, 2024 | 2.048M |
| March 31, 2024 | 1.278M |
| December 31, 2023 | -8.836M |
| September 30, 2023 | -23.22M |
| June 30, 2023 | 13.22M |
| March 31, 2023 | 36.83M |
| December 31, 2022 | 2.021M |
| September 30, 2022 | -36.05M |
| June 30, 2022 | 19.76M |
| March 31, 2022 | 10.95M |
| December 31, 2021 | -24.26M |
| September 30, 2021 | 21.63M |
| June 30, 2021 | 39.70M |
| March 31, 2021 | -4.344M |
| December 31, 2020 | 56.79M |
| September 30, 2020 | 55.94M |
| June 30, 2020 | 32.41M |
| Date | Value |
|---|---|
| March 31, 2020 | 63.82M |
| December 31, 2019 | -126.36M |
| September 30, 2019 | 28.63M |
| June 30, 2019 | 41.84M |
| March 31, 2019 | 34.11M |
| December 31, 2018 | 8.328M |
| September 30, 2018 | -149.26M |
| June 30, 2018 | -97.33M |
| March 31, 2018 | -40.29M |
| December 31, 2017 | -20.36M |
| September 30, 2017 | 70.61M |
| June 30, 2017 | 2.41M |
| March 31, 2017 | -44.92M |
| December 31, 2016 | 4.811M |
| September 30, 2016 | -31.15M |
| June 30, 2016 | 18.56M |
| March 31, 2016 | 22.66M |
| December 31, 2015 | -56.42M |
| September 30, 2015 | -0.252M |
| June 30, 2015 | 0.038M |
| March 31, 2015 | -0.328M |
| December 31, 2014 | -1.021M |
| September 30, 2014 | -0.082M |
| June 30, 2014 | -0.278M |
| March 31, 2014 | -0.057M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Praxis Precision Medicines, Inc. | 10.98M |
| Tonix Pharmaceuticals Holding Corp. | -0.5769M |
| ACADIA Pharmaceuticals, Inc. | -8.529M |
| Alnylam Pharmaceuticals, Inc. | -363.46M |
| Anika Therapeutics, Inc. | -1.28M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.213M |
| Cash from Financing (Quarterly) | 0.082M |
| Free Cash Flow | -12.14M |
| Free Cash Flow Per Share (Quarterly) | -0.0124 |
| Free Cash Flow to Equity (Quarterly) | -9.071M |
| Free Cash Flow to Firm (Quarterly) | -2.351M |
| Free Cash Flow Yield | -20.69% |